zensun shanghai science technology co ltd
Zensun Announces Ph II Results For Neucardin™ Heart Failure Drug
Zensun Sci & Tech, Ltd. announced Thursday positive results of four completed Phase II clinical trials for its anti-heart failure drug, Neucardin™.
SciClone Licenses Chronic Heart Failure Drug From Zensun
SciClone Pharma has licensed from Zensun (Shanghai) Science & Technology Co. Ltd. its chronic heart failure drug, Neucardin.




